Clinical Trial Update: Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Ombrabulin (AVE8062) in combination with taxane- and platinum-based chemotherapy for non-small cell lung cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Ombrabulin (AVE8062) (Ombrabulin)
• Platinum-based chemotherapy (platinum-based chemotherapy)
• Taxane-based chemotherapy

Snippet

Sponsor: Sanofi | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED